DUBLIN, Mar, 06, 2014 /PRNewswire/ --Research and Markets (http://www.researchandmarkets.com/research/dwqqfq/research_report) has announced the addition of the "Concise Analysis of the International and Chinese Human Vaccine Industry" report to their offering.
The research object of the report is human vaccines. According to different types and sources, vaccines can be divided into pathogenic protein vaccine, recombinant protein vaccines, immune protein vaccines and gene vaccines.
In China, vaccines are generally divided into Vaccine I and Vaccine II. Vaccine I is offered for free, and it's priced and purchased uniformly by the government, covering the major epidemic diseases of Hepatitis B, epidemic cerebrospinal meningitis, Tetanus, etc. Vaccine II is other vaccines inoculated voluntarily at residents' own expense. It is independently priced and has large profit margins, but there are intense competition in the market. The frequently-used Vaccine II includes Pneumonia vaccine, Varicella Vaccine, Type B Haemophilus Influenzae Conjugate Vaccine, Influenza Vaccine, Rabies Vaccine and so on. In China, Vaccine I market are occupied by state-owned enterprises, while foreign-funded enterprises and private enterprises have certain advantages in Vaccine II market.
In 2012, the scale of Chinese vaccine market was about CNY 19 billion, while the scale of pharmaceutical industry was about CNY 1.78 trillion in the same period. The sales revenue of Chinese vaccine industry was only about 1% of that of the pharmaceutical industry far below the global average level of 3%, estimated by CRI. There is still much space for growth. China has the largest population in the world with 10 million newborns yearly. Meanwhile, the aging of the society is increasingly serious.
Key Topics Covered:
1 Basic Concept of Human Vaccine Industry
2 Analysis on Global Vaccine Market, 2008-2012
3 Development Environment of China Vaccine Industry, 2012-2013
4 Analysis on China's Human Vaccine Market, 2008-2012
5 China's Major Vaccine Manufacturers
6 Prediction on Development of China Vaccine Industry
- Beijing Tiantan Biological Products
- Changchun High-Tech Industry
- China National Biotec Group
- Haiwang Yingtelong Biotechnology
- Hualan Biological Engineering
For more information visit http://www.researchandmarkets.com/research/dwqqfq/research_report
Media Contact: Laura Wood , +353-1-481-1716, email@example.com
SOURCE Research and Markets